Coding Ahead
CasePilot
Medical Coding Assistant
CaseConsultant
Instant Email Coding Consultant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Creatine kinase (CK), (CPK); total

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Creatine kinase (CK), also referred to as creatine phosphokinase (CPK), is an important enzyme that plays a critical role in energy production within various tissues of the body, particularly in the heart, brain, and skeletal muscle. This enzyme exists in several subtypes, which include CK-MM, predominantly found in skeletal and heart muscle, CK-MB, which is specific to heart muscle, and CK-BB, located in the brain. In the bloodstream, the presence of CK-BB is rare, with the majority of circulating CK being either CK-MM or CK-MB. Elevated levels of CK in the blood can indicate damage to heart muscle, such as that occurring during a heart attack (myocardial infarction), or injury to skeletal muscle, which may result from trauma or intense physical activity. Additionally, certain factors such as the use of statin medications, which are designed to lower cholesterol levels, and alcohol consumption can also lead to increased CK levels in the blood. The CPT® code 82550 specifically pertains to a laboratory test that measures the total creatine kinase (CK) levels in a blood sample. This test is performed by obtaining a blood specimen through a separately reportable venipuncture, and the serum or plasma is analyzed using quantitative enzymatic methodology. Understanding total CK levels is essential for diagnosing and monitoring conditions related to muscle damage.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The creatine kinase (CK) test, identified by CPT® code 82550, is indicated for various clinical scenarios where muscle damage may be suspected. The following conditions and symptoms warrant the performance of this test:

  • Heart Muscle Damage Elevated CK levels can indicate damage to the heart muscle, such as that occurring during a myocardial infarction (heart attack).
  • Skeletal Muscle Injury Conditions involving trauma or injury to skeletal muscle, which may result in elevated CK levels, are also indications for this test.
  • Monitoring Muscle Disorders The test may be used to monitor patients with known muscle disorders or conditions that could lead to muscle damage.
  • Assessment of Statin Effects Patients on statin medications may require CK testing to assess for potential muscle-related side effects.

2. Procedure

The procedure for performing the creatine kinase (CK) test involves several key steps to ensure accurate measurement of total CK levels:

  • Step 1: Patient Preparation Prior to the test, the patient may be advised to avoid strenuous exercise and certain medications that could affect CK levels, such as statins, to ensure accurate results.
  • Step 2: Venipuncture A qualified healthcare professional performs a venipuncture to obtain a blood specimen. This step is crucial as the blood sample must be collected in a manner that minimizes hemolysis, which can interfere with test results.
  • Step 3: Sample Handling The collected blood specimen is then processed to separate the serum or plasma, which is necessary for the subsequent analysis of CK levels.
  • Step 4: Laboratory Analysis The serum or plasma is analyzed using quantitative enzymatic methodology to measure the total creatine kinase levels. This analysis is performed in a laboratory setting, ensuring adherence to quality control standards.

3. Post-Procedure

After the creatine kinase (CK) test is completed, the patient may be advised to resume normal activities unless otherwise directed by their healthcare provider. It is important to monitor for any adverse reactions at the venipuncture site, such as excessive bleeding or signs of infection. The results of the CK test will be interpreted by the healthcare provider in conjunction with the patient's clinical history and other diagnostic tests to determine the presence and extent of muscle damage. Follow-up testing may be necessary based on the initial results and the clinical context.

Short Descr ASSAY OF CK (CPK)
Medium Descr CREATINE KINASE TOTAL
Long Descr Creatine kinase (CK), (CPK); total
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) Yes
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 3
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
QW Clia waived test
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GA Waiver of liability statement issued as required by payer policy, individual case
Q4 Service for ordering/referring physician qualifies as a service exemption
GW Service not related to the hospice patient's terminal condition
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
93 Synchronous telemedicine service rendered via telephone or other real-time interactive audio-only telecommunications system : synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located away at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that is sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction.
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
AY Item or service furnished to an esrd patient that is not for the treatment of esrd
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
CR Catastrophe/disaster related
GC This service has been performed in part by a resident under the direction of a teaching physician
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GZ Item or service expected to be denied as not reasonable and necessary
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
PN Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QP Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060.
SA Nurse practitioner rendering service in collaboration with a physician
X1 Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"